P-2034. Evaluation of Implementing Text-Messaging Based Medication Reminders to Improve Adherence to Antiretrovirals in People Living with HIV

Abstract Background Maintaining virologic suppression through antiretroviral treatment (ART) is essential for optimizing the health outcomes of people living with HIV (PWH) and reducing transmission risk. Virologic suppression requires strict adherence to ART regimens. Many PWH find oral regimen adherence to be challenging; however, text reminders are a potential tool that can support adherence. To determine if implementation of text reminders from healthcare providers supported adherence, viral suppression, and patient satisfaction, we implemented a customizable SMS-based medication text reminder service offered to individuals receiving HIV care in order determine impact. Methods Patients (≥18 years, PWH) at Boston Medical Center were enrolled in the texting service by clinical staff from 02/19/22 to 03/08/24 (N=47). Participants could fully customize the timing, content, and language of their reminders. Demographic and viral load (VL) data were extracted from the medical record, including baseline VL before enrollment and most recent VL as of 09/30/24 or closest to service disenrollment. McNemar’s test was used to assess association between VL suppression and exposure to the texting service (N=37). Virologic suppression was defined as < 200 copies/mL. Perceived adherence and satisfaction were assessed through optional text surveys among participants enrolled ≥30 days (N=21); four also completed follow-up phone interviews. Results Table 1 shows the N=37 individuals enrolled in the text message service with baseline demographics. Median baseline VL was 188 copies/mL with 49% (N=18) unsuppressed at baseline (Table 2). We found a statistically significant difference between pre- and post-intervention VL suppression for patients who enrolled in the reminder service (p=0.0003). Results were also significant among the same patients using a 50 copies/mL threshold (p=0.0019). Survey respondents self-reported improved or maintained medication adherence levels and high satisfaction (Table 3). Conclusion Results suggest the implementation of customizable care team-delivered text medication reminders can be used as a tool to achieve virologic suppression, ART adherence, and continued patient satisfaction. Disclosures Melanie Berry, PharmD, Gilead: Smpliyee Michael Maiullari, PharmD, BCIDP, Gilead Sciences: Advisor/Consultant|ViiV Healthcare: Advisor/Consultant Archana Asundi, MD, DayZero Diagnostics: Grant/Research Support|Gilead Sciences: Advisor/Consultant|Gilead Sciences: Grant/Research Support|Theratechnologies: Grant/Research Support|Viiv Healthcare: Grant/Research Support

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.2198
Primary Topic
Mobile Health and mHealth Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-2034. Evaluation of Implementing Text-Messaging Based Medication Reminders to Improve Adherence to Antiretrovirals in People Living with HIV

Archana Asundi, Diana F. Clarke, Melanie Berry, Michael Maiullari et al.
Open Forum Infectious Diseases
Mobile Health and mHealth Applications
article

P-2034. Evaluation of Implementing Text-Messaging Based Medication Reminders to Improve Adherence to Antiretrovirals in People Living with HIV

Archana Asundi, Diana F. Clarke, Melanie Berry, Michael Maiullari, Athina Schmidt, Alejandra Salazar, Laura Mitten, Mary R Bartkus
article en

Abstract

Abstract Background Maintaining virologic suppression through antiretroviral treatment (ART) is essential for optimizing the health outcomes of people living with HIV (PWH) and reducing transmission risk. Virologic suppression requires strict adherence to ART regimens. Many PWH find oral regimen adherence to be challenging; however, text reminders are a potential tool that can support adherence. To determine if implementation of text reminders from healthcare providers supported adherence, viral suppression, and patient satisfaction, we implemented a customizable SMS-based medication text reminder service offered to individuals receiving HIV care in order determine impact. Methods Patients (≥18 years, PWH) at Boston Medical Center were enrolled in the texting service by clinical staff from 02/19/22 to 03/08/24 (N=47). Participants could fully customize the timing, content, and language of their reminders. Demographic and viral load (VL) data were extracted from the medical record, including baseline VL before enrollment and most recent VL as of 09/30/24 or closest to service disenrollment. McNemar’s test was used to assess association between VL suppression and exposure to the texting service (N=37). Virologic suppression was defined as < 200 copies/mL. Perceived adherence and satisfaction were assessed through optional text surveys among participants enrolled ≥30 days (N=21); four also completed follow-up phone interviews. Results Table 1 shows the N=37 individuals enrolled in the text message service with baseline demographics. Median baseline VL was 188 copies/mL with 49% (N=18) unsuppressed at baseline (Table 2). We found a statistically significant difference between pre- and post-intervention VL suppression for patients who enrolled in the reminder service (p=0.0003). Results were also significant among the same patients using a 50 copies/mL threshold (p=0.0019). Survey respondents self-reported improved or maintained medication adherence levels and high satisfaction (Table 3). Conclusion Results suggest the implementation of customizable care team-delivered text medication reminders can be used as a tool to achieve virologic suppression, ART adherence, and continued patient satisfaction. Disclosures Melanie Berry, PharmD, Gilead: Smpliyee Michael Maiullari, PharmD, BCIDP, Gilead Sciences: Advisor/Consultant|ViiV Healthcare: Advisor/Consultant Archana Asundi, MD, DayZero Diagnostics: Grant/Research Support|Gilead Sciences: Advisor/Consultant|Gilead Sciences: Grant/Research Support|Theratechnologies: Grant/Research Support|Viiv Healthcare: Grant/Research Support

Open Forum Infectious DiseasesVol. 13(Supplement_1)
Boston Medical Center (US), Gilead Sciences (United Kingdom) (GB), Gilead Sciences (Australia) (AU)
Quality Education
Openalex Percentile: Top 92%
Mobile Health and mHealth Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.